|Articles|November 17, 2020

COVID-19 Update: US and Global Cases, Deaths, and Recoveries as of November 17, 2020

US confirmed cases of COVID-19 have surpassed 11 million; global cases have reached 55 million. We summarize more of today's data from the Johns Hopkins COVID-19 interactive map.

How many cases of coronavirus disease 2019 (COVID-19) have been confirmed in the US?

According to the Johns Hopkins COVID-19 interactive map, as of today, November 17, 2020 at 10:27 AM, EDT, there have been:

• 11 214 231 confirmed cases
• 247 437 deaths
• 4 244 811 recoveries

The 5 states with the highest total confirmed cases are:

1. Texas: 1 067 085
2. California: 1 044 349
3. Florida: 889 864
4. Illinois: 585 248
5. New York: 563 690

Deaths: New York has the most deaths due to COVID-19 with 34 054 reported fatalities, followed by Texas with 20 032 deaths, and California with 18 306.

Recoveries: Texas leads in recoveries from COVID-19 with 875 521 people who have recovered, followed by North Carolina with 276 132 recoveries and Tennessee with 271 864.

Tests administered: California leads in number of persons tested with 21 068 894 people tested, followed by New York with 16 876 843 people tested, and Texas with 9 378 611 people tested.

How many cases of COVID-19 have been confirmed globally?

Globally, there have been 55 204 949 confirmed cases, 1 330 299 deaths, and 35 490 309 recoveries.

For more COVID-19 coverage for primary care, visit our COVID-19 Resource Page.

Enhance your clinical practice with the Patient Care newsletter, offering the latest evidence-based guidelines, diagnostic insights, and treatment strategies for primary care physicians.

Subscribe Now!

Latest CME

Virtual Event

Examining the Role of ctDNA in the Management of Breast Cancer: Latest Evidence and Future Directions

October 15, 2025

COVID-19 Update: US and Global Cases, Deaths, and Recoveries as of November 17, 2020

How many cases of coronavirus disease 2019 (COVID-19) have been confirmed in the US?

How many cases of COVID-19 have been confirmed globally?

For more COVID-19 coverage for primary care, visit our COVID-19 Resource Page.

Newsletter

Related Content

AAA Screening in Primary Care: Criteria, Implementation, and Patient Communication

FDA Accepts MannKind sBLA for Inhaled Insulin for Children and Adolescents with Diabetes

Kabiul Haque, MD, on Effective Management of Peripheral Arterial Disease in Primary Care

Low-Dose Aspirin May be Widely Overused for CVD Prevention Based on PREVENT Estimates

GLP-1 RAs Linked to Atypical Uptake on PET-CT Scans, Raising Interpretation Challenges

Latest CME

Examining the Role of ctDNA in the Management of Breast Cancer: Latest Evidence and Future Directions

Rapid Reviews in Retina™: Emerging Updates from Winter 2024 – Addressing the Wealth of New Data in Treatments for nAMD and DME (Cope Credit)

Rapid Reviews in Retina™: Emerging Updates from Winter 2024 – Addressing the Wealth of New Data in Treatments for nAMD and DME (CME Track)

Medical Crossfire®: Integrating Real-World Data to Improve Outcomes for Patients With Multiple Sclerosis

Medical Crossfire® - Optimizing Management for Patients With Generalized Myasthenia Gravis: Focus on Complement Inhibitors

Collaborating Across the Continuum™: Identifying and Preventing Hepatic Encephalopathy in Long-Term Care Settings

(MOC and CME Credit) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment

(CME Credit Only) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment

Evolving Perspectives in Alzheimer Disease : Reaching an Earlier Diagnosis, Understanding Neuroinflammation, and Exploring Therapeutic Advances

Community Practice Connections™: Optimizing the Management of Tardive Dyskinesia—Addressing the Complexity of Care With Targeted Treatment

(CME) Optimizing Management of Ocular Toxicity in Cancer Patients: The Role of Ophthalmologists in the Spectrum of Care

(MOC and CME Credit) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure

(CME Credit Only) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure

Burst CME™: Setting the Stage – Individualizing Migraine Care for Diverse Populations Across Care Settings

Community Collab: A Round Table Exploration of Effective Anesthesia with Vasoconstriction in Head and Neck Surgery

43rd Annual CFS®: Innovative Cancer Therapy for Tomorrow™

20th Annual New York Lung Cancers Symposium®

GI Cancers Symposia

DSUI Urology on the Beach

10th Annual Live Medical Crossfire®: Hematologic Malignancies

27th Annual International Lung Cancer Congress®

The ENT Surgeon's Edge: The Case for Effective Anesthesia with Vasoconstriction

Cases and Conversations: Evidence-Based Approaches to Management of CKD in Your Patients With T2DM

Lung Cancer Tumor Board: Enhancing Precision Medicine in NSCLC Through Advancements in Molecular Testing and Optimal Therapy Selection

Interventional Glaucoma: The Convergence of Surgical Innovation and Therapeutic Hope

Antibody–Drug Conjugates in Oncology: The Essentials of AE Management for Better Patient Outcomes

Patient, Provider & Caregiver Connection™: Understanding the Patient Journey to Provide Personalized Care for Generalized Pustular Psoriasis

SimulatED™: Understanding the Role of Genetic Testing in Patient Selection for Anti-Amyloid Therapy

Expert Illustrations & Commentaries™: Visualizing the Role of B Cells as Therapeutic Targets for Generalized Myasthenia Gravis

Unlocking the Future of Glioma Care: Integrating Recent Advances to Personalize Treatment

Southern Florida Psychiatry Conference

Annual Hematology Meeting: Preceding the 67th ASH Annual Meeting and Exposition

Breast Cancer Symposia in San Antonio

Inaugural Brain & Spine Metastases Conference: Evolving Practice and Emerging Therapies

23rd Annual Winter Lung Cancer Conference®

From Clue to Care: Rapid Recognition and Coordinated Management of Paraneoplastic LEMS in SCLC

Medical Crossfire® in Adjunctive Testing: Charting a New Course in Prostate Cancer Risk Assessment

Community Oncology Connections™: Beyond the Basics—Revolutionizing Advanced Prostate Cancer Management With PSMA-Targeted Therapies | Washington

Community Oncology Connections™: Enhancing Melanoma Outcomes With Intratumoral Oncolytic Immunotherapy – Strategies for the Multidisciplinary Team | Tennessee

Community Oncology Connections™: Beyond the Basics— Revolutionizing Advanced Prostate Cancer Management With PSMA-Targeted Therapies | Montana and Wyoming

SimulatEd™: Patient-Centered Care to Improve Outcomes in Chronic Lymphocytic Leukemia

Community Oncology Connections™: Enhancing Melanoma Outcomes With Intratumoral Oncolytic Immunotherapy – Strategies for the Multidisciplinary Team | Arizona

Community Oncology Connections™: Beyond the Basics—Revolutionizing Advanced Prostate Cancer Management With PSMA-Targeted Therapies | Louisiana

Optometrists: Earn COPE CE Credits in Portland or Virtually

Join us at The Ophthalmology Meeting in Orlando this October

A New Era of Targeted Therapy for Advanced NSCLC: Exploring Future Directions for Bispecific Antibodies and ADCs

Tumor Board: Advances in Managing EGFR-Mutant NSCLC—Applying Evidence Across the Disease Continuum

4th Women in Neurology Conference

Community Oncology Connections™: Beyond the Basics—Revolutionizing Advanced Prostate Cancer Management With PSMA-Targeted Therapies | Nevada

(COPE) Optimizing Management of Ocular Toxicity in Cancer Patients: The Role of Ophthalmologists in the Spectrum of Care

Burst CME™: Optimizing Migraine Management – Addressing Unmet Needs, Individualizing Care for Diverse Populations, and Utilizing CGRP Targeted Agents

Burst CME™: Optimizing the Use of CGRP Targeted Agents for the Treatment of Migraine

Burst CME™: The Patient Journey – Unmet Needs From Diagnosis Through Management of Migraine

Community Practice Connections™: Transforming Treatment in nAMD, DME, and DR – Keeping an Eye on Optimal Outcomes

Raising Our Game in the Management of Hyperlipidemia: New Targets, New Tactics

Medical Crossfire®: New Horizons in Hemolytic Anemias – How I Diagnose & Treat Based on Individual Patient and Disease Characteristics

Cases and Conversations™: Applying Practice Techniques to Optimize Diagnosis and Treatment Strategies in Generalized Pustular Psoriasis

Tackling Inequities in IBD: Inclusive Solutions for Elevated Patient Care

4th Annual International Congress on Pediatric Oncology

Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice

23rd Annual School of Breast Oncology

Community Oncology Connections™: Enhancing Melanoma Outcomes With Intratumoral Oncolytic Immunotherapy – Strategies for the Multidisciplinary Team | Iowa

26th Annual International Lung Cancer Congress

Community Oncology Connections™: Enhancing Melanoma Outcomes With Intratumoral Oncolytic Immunotherapy – Strategies for the Multidisciplinary Team | New York

Community Oncology Connections™: Beyond the Basics—Revolutionizing Advanced Prostate Cancer Management With PSMA-Targeted Therapies | South Carolina

Community Oncology Connections™: Enhancing Melanoma Outcomes With Intratumoral Oncolytic Immunotherapy – Strategies for the Multidisciplinary Team | Minnesota

PER Psych Summit: Integrating Shared Decision-Making Into Management Plans for Patients With Schizophrenia

Expert Perspectives on Technological Advances in Cataract Surgery